EVAX — Evaxion Biotech A/S Cashflow Statement
0.000.00%
Last trade - 00:00- $10.61m
- $15.90m
- $0.07m
Annual cashflow statement for Evaxion Biotech A/S, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.2 | -15 | -24.5 | -23.2 | -22.1 |
| Depreciation | |||||
| Non-Cash Items | 2.87 | 1.48 | 0.197 | -0.881 | 0.725 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.22 | 0.997 | 2.06 | -2.29 | 3.09 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.03 | -12.4 | -21.9 | -25.8 | -17.7 |
| Capital Expenditures | -0.061 | -0.184 | -1.36 | -0.292 | -0.087 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.209 | 0.03 | 0.024 | -0.006 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.061 | -0.393 | -1.33 | -0.268 | -0.093 |
| Financing Cash Flow Items | -0.013 | -0.128 | -3.76 | 0 | -0.432 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.51 | 8.82 | 49.8 | 7.85 | 10.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.13 | -3.73 | 26.3 | -19 | -7.6 |